Oramed Pharmaceuticals (ORMP) Minority Interest (2021 - 2025)
Oramed Pharmaceuticals (ORMP) reported Minority Interest of -$952000.0 for Q3 2025, down 3.59% on a YoY basis from -$987458.2 in Q3 2024, and down 0.63% quarter-over-quarter from -$946000.0 in Q2 2025.
Oramed Pharmaceuticals (ORMP) Minority Interest (2021 - 2025) Analysis & Trends
Oramed Pharmaceuticals has reported Minority Interest for 5 years, with the latest figure at -$952000.0 in Q3 2025.
- For the quarter ending Q3 2025, Minority Interest fell 3.59% year-over-year to -$952000.0; the trailing twelve-month figure through Sep 2025 stood at -$952000.0 (down 3.59% YoY), and the FY2024 full-year result was -$918000.0, up 1.08% from the prior year.
- Minority Interest for Q3 2025 stood at -$952000.0, down from -$946000.0 in the prior quarter.
- The five-year high for Minority Interest was $1.1 million in Q2 2021, with the low at -$952000.0 in Q3 2025.
- Historically, Minority Interest has averaged -$542833.3 across 5 years, with a median of -$896500.0 in 2023.
- Annual changes were most pronounced in 2023 — Minority Interest slumped 552.38% — and 2024, when it increased 1.08%.
- Oramed Pharmaceuticals' Minority Interest stood at $536000.0 in 2021, then tumbled by 222.39% to -$656000.0 in 2022, then sank by 41.46% to -$928000.0 in 2023, then climbed by 1.08% to -$918000.0 in 2024, then declined by 3.7% to -$952000.0 in 2025.
- The last three Minority Interest figures came in at -$952000.0 (Q3 2025), -$946000.0 (Q2 2025), and -$918000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -952,000.00 |
| Jun 30, 2025 | -946,000.00 |
| Mar 31, 2025 | -918,000.00 |
| Dec 31, 2024 | -918,000.00 |
| Sep 30, 2024 | -919,000.00 |
| Jun 30, 2024 | -911,000.00 |
| Mar 31, 2024 | -918,000.00 |
| Dec 31, 2023 | -928,000.00 |
| Sep 30, 2023 | -902,000.00 |
| Jun 30, 2023 | -891,000.00 |
| Mar 31, 2023 | -822,000.00 |
| Dec 31, 2022 | -656,000.00 |
| Sep 30, 2022 | -661,000.00 |
| Jun 30, 2022 | -660,000.00 |
| Mar 31, 2022 | -126,000.00 |
| Nov 30, 2021 | 536,000.00 |
| Aug 31, 2021 | 744,000.00 |
| May 31, 2021 | 1.08 Mn |